Global Wound Care Biologics Market Forecast to Reach $11.96 Billion by 2029, Driven by 7.8% CAGR
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Much Is the Global Wound Care Biologics Market Valued at Present and by 2029?
In recent years, the nuclear medicine radioisotopes market has seen substantial growth. It is projected to increase from $8.21 billion in 2024 to $8.85 billion in 2025, representing a compound annual growth rate (CAGR) of 7.9%. The growth during the historical period can be ascribed to the discovery of radioactivity, the development of nuclear medicine, therapeutic uses, clinical studies, and demands from patients.
It is anticipated that the nuclear medicine radioisotopes market will undergo substantial expansion in the coming years, and it’s projected to reach an estimated worth of $11.96 billion in 2029, expanding at a compound annual growth rate (CAGR) of 7.8%. The predicted surge over the forecast period is linked to factors such as rising expenditure in healthcare, improvements in healthcare facilities, increasing consciousness about environmental sustainability, educational drives and awareness initiatives, and the rise of medical tourism. The forecast period also sees trends like the invention of new radioisotopes, breakthroughs in production and supply chain, microfluidics and lab-on-a-chip technology, the use of artificial intelligence in developing radiopharmaceuticals and the application of nanotechnology.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16132&type=smp
#What Drivers Are Influencing Growth In The Wound Care Biologics Market?
The escalating incidence of diabetes is anticipated to boost the rise of the wound care biologics market in the imminent future. Diabetes is a long-term metabolic disorder signified by increased levels of blood glucose (or blood sugar), which over time inflicts devastating damage to the heart, blood vessels, eyes, kidneys, and nerves. Biological wound care thwarts excessive water loss, thermal loss, protein and electrolyte loss, plus contamination. Furthermore, they facilitate autolytic debridement and create a granular wound layer. The elevated incidence of diabetes is a key factor propelling the growth of the wound care biologics market. For instance, as per the National Health Service (NHS), a UK-based government agency, the count of individuals under 40 affected, surged from 173,166 in 2022 to 216,440 in 2023 in June 2024. This marked escalation delineates a worrying pattern in this age demographic. The statistics underscore a fast acceleration in diabetes prevalence amongst the younger cohorts. Hence, the rampant incidence of diabetes is fuelling the wound care biologics market.
The nuclear medicine radioisotopes market covered in this report is segmented –
1) By Type: Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Iodine (I-123), Fluorine-18, Rubidium-82 (Rb-82), Iodine-131 (I-131), Lutetium-177 (Lu-177), Radium-223 (Ra-223) And Alpharadin, Other Types
2) By Application: Oncology, Cardiology, Thyroid, Neurology, Other Applications
3) By End-User: Hospitals, Diagnostic Centers, Specialty Clinics, Education And Research Institutes, Other End-Users
Subsegments:
1) By Technetium-99m (Tc-99m): Sodium Pertechnetate Tc-99m, Tc-99m MDP (Methylene Diphosphonate), Tc-99m HMPAO (Hexamethylpropyleneamine oxime)
2) By Thallium-201 (Tl-201): Thallous Chloride Tl-201, Thallium-201 for Cardiac Imaging
3) By Iodine-123 (I-123): Iodine-123 Sodium Iodide, Iodine-123 Ioflupane (DaTscan)
4) By Fluorine-18: FDG (Fluorodeoxyglucose) F-18, Fluoride-18 For Bone Imaging
5) By Rubidium-82 (Rb-82): Rb-82 For PET (Positron Emission Tomography) Imaging, Rb-82 For Cardiac Imaging
6) By Iodine-131 (I-131): I-131 Sodium Iodide, I-131 For Thyroid Cancer Treatment, I-131 For Hyperthyroidism Treatment
7) By Lutetium-177 (Lu-177): Lu-177-DOTATATE, Lu-177 For Prostate Cancer Treatment
8) By Radium-223 (Ra-223): Ra-223 Dichloride (Xofigo)
9) By Alpharadin (Radium-223 Alpha Emitters): Alpharadin For Bone Metastasis Treatment
10) By Other Types: Ac-225 For Targeted Alpha Therapy (TAT), Ac-225 For Cancer Treatment, Gallium-68 (Ga-68), Copper-64 (Cu-64), Yttrium-90 (Y-90)
What Trends Are Currently Influencing Growth In The Wound Care Biologics Market?
Leading businesses in the nuclear medicine radioisotopes market are honing their focus on the creation of innovative products like the compact low-energy cyclotron. This technology is aimed at enhancing the production and accessibility of radioisotopes, thereby ensuring that diagnostic and therapeutic options are more efficient and readily available. A compact low-energy cyclotron, essentially a mini particle accelerator, is employed in the creation of radioisotopes for medical imaging and treatments within the realm of nuclear medicine. As an exemplification, IBA, a Belgium-based company supplying solutions for radiopharmaceutical production, announced the launch of the Cyclone Key in January of 2022. This new accelerator aims to expand access to diagnostic solutions and enable in-house production of radiopharmaceuticals. This forward-thinking solution brings unique features to the table, including a compact and efficient design, complete automation, multiple isotope production abilities, water cooling, self-shielding, and high performance. This renders it versatile and trustworthy.
Which Companies Play A Key Role In The Development Of The Wound Care Biologics Market?
Major companies operating in the nuclear medicine radioisotopes market are Cardinal Health Inc., Bayer AG, Siemens Healthineers AG, GE HealthCare Technologies, BWX Technologies Inc., Mallinckrodt Pharmaceuticals, Bracco Imaging S.p.A., Lantheus Holdings Inc., Curium Pharma, Australian Nuclear Science and Technology Organisation (ANSTO) Health, Eckert & Ziegler Strahlen, NorthStar Medical Radioisotopes, NTP Radioisotopes, Shine Medical Technologies Inc., Jubilant DraxImage Inc., Isotopia Molecular Imaging Ltd., Eczacıbaşı-Monrol Nuclear Products, International Isotopes Inc., Polatom Sp. z o.o., Radiomedix Inc., Positron Corporation
What Are The Key Regional Developments Shaping The Wound Care Biologics Market?
North America was the largest region in the nuclear medicine radioisotopes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nuclear medicine radioisotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=16132&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
